ORDENTLICH PETER (Chief Scientific Officer) sold 99.0% of their position (25K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $625.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+265.00
Price / share
$14.12
Trade value
$3.74K
% of position
Common Stock
Shares
+22.85K
Price / share
$6.32
Trade value
$144.39K
% of position
Common Stock
Shares
−22.85K
Price / share
$25.04
Trade value
$571.97K
% of position
Common Stock
Shares
+2.15K
Price / share
$6.35
Trade value
$13.68K
% of position
Common Stock
Shares
−2.15K
Price / share
$25.04
Trade value
$53.93K
% of position
Net shares
+265.00
Net value
-$464.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/29/2022 | J · J | +265.00 | $14.12 | $3.74K | New position | 0.00 | 265.00 |
| Common Stock Direct | 8/24/2022 | M · Option Exercise | +22.85K | $6.32 | $144.39K | 8621.1% | 265.00 | 23.11K |
| Common Stock Direct | 8/24/2022 | S · Sale | −22.85K | $25.04 | $571.97K | 98.9% | 23.11K | 265.00 |
| Common Stock Direct | 8/24/2022 | M · Option Exercise | +2.15K | $6.35 | $13.68K | 812.8% | 265.00 | 2.42K |
| Common Stock Direct | 8/24/2022 | S · Sale | −2.15K | $25.04 | $53.93K | 89.0% | 2.42K | 265.00 |
| Total | +265.00 | -$464.09K | ||||||
Stock Options (Right to buy)
Common Stock
2.15K shares
Shares
−2.15K
Strike price
6.35
Held after
0.00
Exercisable
—
Stock Options (Right to buy)
Common Stock
22.85K shares
Shares
−22.85K
Strike price
6.32
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock2.15K shares | 8/24/2022 | M · Option Exercise | −2.15K | 6.35 | — | 0.00 |
| Stock Options (Right to buy) Direct | Common Stock22.85K shares | 8/24/2022 | M · Option Exercise | −22.85K | 6.32 | — | 0.00 |